Abstract

Introduction: A multitude of underlying reasons result in hydrocephalus (HC), and its classification remains controversial. The current study looks at patients with the Syndrome of Hydrocephalus in Young and Middle-Aged adults (SHYMA) through a case series. Patients and methods: We report 35 patients with HC referred to St. Anna Multiprofile Hospital during the period 2008-2012. Inclusion criteria were decompensated congenital hydrocephalus, (DCH), acquired hydrocephalus (AHC), or idiopathic hydrocephalus (IHC) in the age range of 16-55 years, treated with a ventriculo-peritoneal shunt (VPS)- 17 patients were treated with Strata Adjustable Delta Valve ('Strata' group) and 18 patients had Medtronic Orbis Sigma valves inserted ('Orbis Sigma' group). Results: Eight patients (22.86%) had DCH, 14 (40%) had AHC, and 13 (37.14%) had IHC. Regardless the underlying cause for HC, all the patients had similar symptoms, mainly related to gait in 26 (74.3%), cognition in 30 (85.7%), bladder control in 20 (57.14%) and chronic headaches in 24 patients (68.57%). Symptomatic improvement was achieved in 34 of the shunted 35 patients (97.14%), but the postoperative complications rate was found to be significantly lower in the 'Strata' group. Conclusion: The clinical presentation of hydrocephalus in the age 16-55 years has common features presenting with syndrome of hydrocephalus in young and middle-aged adults as separate clinical entity. VPS is a feasible treatment option in SHYMA. Due to the excessive, long standing ventriculomegaly, thus sensitive compliance of brain parenchyma and high tendency to develop subdural hematomas, adjustable VPS are advisable option.

Highlights

  • A multitude of underlying reasons result in hydrocephalus (HC), and its classification remains controversial

  • Inclusion criteria were decompensated congenital hydrocephalus, (DCH), acquired hydrocephalus (AHC), or idiopathic hydrocephalus (IHC) in the age range of 16–55 years, treated with a ventriculo-peritoneal shunt (VPS) — patients were treated with Strata Adjustable Delta Valve (“Strata” group) and patients had Medtronic Orbis Sigma valves inserted (“Orbis Sigma” group)

  • One group which has tended to be neglected is the age group which includes young to middle aged adults, and it has been proposed that patients in this age group who present with hydrocephalus represent a separate clinical category

Read more

Summary

Introduction

A multitude of underlying reasons result in hydrocephalus (HC), and its classification remains controversial. One group which has tended to be neglected is the age group which includes young to middle aged adults, and it has been proposed that patients in this age group who present with hydrocephalus represent a separate clinical category. LOVA is a relatively new concept — a specific form of non-communicating hydrocephalus that often causes hydrocephalic dementia. Before this new clinical entity was proposed, patients with LOVA had been considered as normal pressure hydrocephalus (NPH) variants [8]. Since descriptions of LOVA presenting in young and middle-aged adults have been largely restricted to obstructive hydrocephalus secondary to aqueductal stenosis. The presentation of hydrocephalus in young and middle-aged adults is of-

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call